Stay updated on Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference5%

- Check30 days agoChange DetectedUpdated page to v3.1.0 with removal of drug-safety/quality topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and addition of the version tag.SummaryDifference0.6%

- Check45 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2; removed the Back to Top element. No substantive changes to core content, pricing, availability, or names.SummaryDifference0.3%

- Check52 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

- Check59 days agoChange DetectedThe web page has been updated to include a new facility name and location in Florence, Italy, along with additional publications related to a clinical study on ganaxolone. Notably, several terms related to neurosteroids and GABA agents have been removed.SummaryDifference9%

- Check73 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Ganaxolone in PCDH19 Epilepsy Clinical Trial page.